Artiva Biotherapeutics, Inc. Common Stock Long-term Investment Intensity

Latest as of September 2024: 23.5%

Artiva Biotherapeutics, Inc. Common Stock long-term investment intensity. Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Long-term Investment Intensity of 23.5% as of September 2024. Long-term investments of $52.97 Million represent 23.5% of total assets of $225.60 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ARTV working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

LT Investment Intensity

23.5%
LT Investments / Total Assets

Long-term Investments

$52.97 Million
USD

Total Assets

$225.60 Million
USD

Country

USA
NASDAQ

Artiva Biotherapeutics, Inc. Common Stock Long-term Investment Intensity by Year (None–None)

Artiva Biotherapeutics, Inc. Common Stock long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for Artiva Biotherapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Artiva Biotherapeutics, Inc. Common Stoc balance sheet assets.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points